These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 15106974
1. Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide. Francesconi LC, Zheng Y, Bartis J, Blumenstein M, Costello C, De Rosch MA. Inorg Chem; 2004 May 03; 43(9):2867-75. PubMed ID: 15106974 [Abstract] [Full Text] [Related]
2. Comparison of the stability of technetium-labeled peptides to challenge with cysteine. Stalteri MA, Bansal S, Hider R, Mather SJ. Bioconjug Chem; 1999 May 03; 10(1):130-6. PubMed ID: 9893974 [Abstract] [Full Text] [Related]
9. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc. Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR. Bioconjug Chem; 1997 May 03; 8(2):146-54. PubMed ID: 9095354 [Abstract] [Full Text] [Related]
10. MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals. Cantorias MV, Howell RC, Todaro L, Cyr JE, Berndorff D, Rogers RD, Francesconi LC. Inorg Chem; 2007 Sep 03; 46(18):7326-40. PubMed ID: 17691766 [Abstract] [Full Text] [Related]
11. Design and synthesis of potent, highly selective vasopressin hypotensive agonists. Stoev S, Cheng LL, Manning M, Wo NC, Szeto HH. J Pept Sci; 2006 Sep 03; 12(9):592-604. PubMed ID: 16625682 [Abstract] [Full Text] [Related]
13. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation. Hoang HN, Bryant GK, Kelso MJ, Beyer RL, Appleton TG, Fairlie DP. Inorg Chem; 2008 Oct 20; 47(20):9439-49. PubMed ID: 18788796 [Abstract] [Full Text] [Related]
14. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor. Stephenson KA, Banerjee SR, Sogbein OO, Levadala MK, McFarlane N, Boreham DR, Maresca KP, Babich JW, Zubieta J, Valliant JF. Bioconjug Chem; 2005 Oct 20; 16(5):1189-95. PubMed ID: 16173797 [Abstract] [Full Text] [Related]
15. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives. Kawulka KE, Sprules T, Diaper CM, Whittal RM, McKay RT, Mercier P, Zuber P, Vederas JC. Biochemistry; 2004 Mar 30; 43(12):3385-95. PubMed ID: 15035610 [Abstract] [Full Text] [Related]
16. Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. Bates SM, Lister-James J, Julian JA, Taillefer R, Moyer BR, Ginsberg JS. Arch Intern Med; 2003 Feb 24; 163(4):452-6. PubMed ID: 12588204 [Abstract] [Full Text] [Related]